Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 15,335 | 14,105 | 16,816 | 15,133 | 14,960 |
| Operating Income | -15,335 | -14,105 | -16,816 | -15,133 | -14,960 |
| Other Income | 609 | 853 | 986 | 1,049 | 1,053 |
| Pre-tax Income | -14,726 | -13,252 | -15,830 | -14,084 | -13,907 |
| Net Income Continuous | -14,726 | -13,252 | -15,830 | -14,084 | -13,907 |
| Net Income | $-14,726 | $-13,252 | $-15,830 | $-14,084 | $-13,907 |
| EPS Basic Total Ops | -33.00 | -31.00 | -37.00 | -33.00 | -32.00 |
| EPS Basic Continuous Ops | -33.95 | -30.61 | -36.66 | -32.63 | -31.64 |
| EPS Diluted Total Ops | -33.00 | -31.00 | -37.00 | -33.00 | -32.00 |
| EPS Diluted Continuous Ops | -33.95 | -30.61 | -36.66 | -32.63 | -31.64 |
| EBITDA(a) | $-15,267 | $-14,035 | $-16,745 | $-15,063 | $-14,892 |